Already facilitating 2 million medical appointments between medical professionals and patients, health tech company 1st Group (ASX: 1ST) is set to significantly grow its network with the launch of telehealthclinics.com.au – a dedicated site for booking medical appointments to be conducted via teleconference. Whilst COVID-19 has significantly heightened public interest in telehealth, 1st Group has
Read More
Biotech company Genetic Signatures (ASX: GSS) is poised to play a major role in flattening the curve of coronavirus cases in Australia after the Therapeutics Goods Association (TGA) approved their SARS-CoV-2 Detection Kit for sale in Australia. Regulatory approval in Australia follows authorisation which was granted in Europe 10 days ago with Genetic Signatures able
Read More
As the world battles the coronavirus pandemic, G Medical (ASX: GMV) has secured authorisation from the Food and Drug Administration to sell their Prizma smartphone attachment direct to customers without the need for a prescription, rocketing the company’s share price. Prizma, a smartphone attachment which can monitor a user’s vital signs, can play a vital
Read More
As an industry which had already been fighting for survival before the coronavirus pandemic, the stark reality is that the retail sector will never recover from the fallout of COVID-19. Walking through the corridors of Highpoint Shopping Centre during normal trading hours, more than 80% of retail stores had shut their doors, the only ones
Read More
As society is bunkered down in self-isolation to prevent the spread of COVID-19, fintech company Novatti (ASX: NOV) has acquired payments platform Emersion with both businesses seeing a rise in online payment processing revenue to accommodate the new contact-free world. The acquisition will see Emersion integrated into Novatti, bringing with it the $1.7m in revenue
Read More
Australian medtech company Cyclopharm (ASX: CYC) is set to add the United States to the list of 59 countries which have approved Technegas®, its nuclear functional ventilation imaging agent, having lodged its New Drug Application (NDA) with the Food and Drug Administration (FDA). As the world’s largest nuclear medicine market in the world, the opportunity
Read More